Global Montelukast Sodium Market Size, Share, and COVID-19 Impact Analysis, By Dosage Form (Tablets, Oral Solutions, Simple Pills, Chewable Pills, Powder & Others), By Application (Asthma, Allergic Rhinitis, Urticaria, & Other), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033

Industry: Healthcare
RELEASE DATE Feb 2026
REPORT ID SI3889
PAGES 200
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Dosage Form
      2. Market Attractiveness Analysis By Application
      3. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Rising asthma prevalence, generic adoption, cost-effective therapies, pediatric usage worldwide
    3. Restraints
      1.  Side effect concerns, regulatory scrutiny, competition from alternative leukotriene modifiers
    4. Opportunities
      1.  Emerging markets growth, improved formulations, combination therapies, and increasing respiratory awareness
    5. Challenges

5.5.1.     Price pressure, patent expirations, safety warnings, physician preference for substitutes

  1. Global Montelukast Sodium Market Analysis and Projection, By Dosage Form
    1. Segment Overview
    2. Tablets
    3. Oral Solutions
    4. Simple Pills
    5. Chewable Pills
    6. Others
  2. Global Montelukast Sodium Market Analysis and Projection, By Application
    1. Segment Overview
    2. Asthma
    3. Allergic Rhinitis
    4. Urticaria
    5. Others
  3.  Global Montelukast Sodium Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  4. Global Montelukast Sodium Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Montelukast Sodium Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  5. Company Profiles
    1. Cipla
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Merck & Co
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Hetero Labs 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   Ortin laboratories 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Mylan N.V 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Morepen laboratories
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Teva Pharmaceuticals
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. MSN Laboratories
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Vamsi Labs
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Medopharm 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Others
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

List of Table

  1. Global Montelukast Sodium Market, By Dosage Form, 2024-2035(USD Billion)
  2. Global Tablets, Montelukast Sodium Market, By Region, 2024-2035(USD Billion)
  3. Global Oral Solutions, Montelukast Sodium Market, By Region, 2024-2035(USD Billion)
  4. Global Simple Pills, Montelukast Sodium Market, By Region, 2024-2035(USD Billion)
  5. Global Chewable Pills, Montelukast Sodium Market, By Region, 2024-2035(USD Billion)
  6. Global Others, Montelukast Sodium Market, By Region, 2024-2035(USD Billion)
  7. Global Montelukast Sodium Market, By Application, 2024-2035(USD Billion)
  8. Global Asthma, Montelukast Sodium Market, By Region, 2024-2035(USD Billion)
  9. Global Allergic Rhinitis, Montelukast Sodium Market, By Region, 2024-2035(USD Billion)
  10. Global Urticaria, Montelukast Sodium Market, By Region, 2024-2035(USD Billion)
  11. Global Others, Montelukast Sodium Market, By Region, 2024-2035(USD Billion)
  12. North America Montelukast Sodium Market, By Dosage Form, 2024-2035(USD Billion)
  13. North America Montelukast Sodium Market, By Application, 2024-2035(USD Billion)
  14. U.S.  Montelukast Sodium Market, By Dosage Form, 2024-2035(USD Billion)
  15. U.S.  Montelukast Sodium Market, By Application, 2024-2035(USD Billion)
  16. Canada Montelukast Sodium Market, By Dosage Form, 2024-2035(USD Billion)
  17. Canada Montelukast Sodium Market, By Application, 2024-2035(USD Billion)
  18. Mexico Montelukast Sodium Market, By Dosage Form, 2024-2035(USD Billion)
  19. Mexico Montelukast Sodium Market, By Application, 2024-2035(USD Billion)
  20. Europe Montelukast Sodium Market, By Dosage Form, 2024-2035(USD Billion)
  21. Europe Montelukast Sodium Market, By Application, 2024-2035(USD Billion)
  22. Germany Montelukast Sodium Market, By Dosage Form, 2024-2035(USD Billion)
  23. Germany Montelukast Sodium Market, By Application, 2024-2035(USD Billion)
  24. France Montelukast Sodium Market, By Dosage Form, 2024-2035(USD Billion)
  25. France Montelukast Sodium Market, By Application, 2024-2035(USD Billion)
  26. U.K.  Montelukast Sodium Market, By Dosage Form, 2024-2035(USD Billion)
  27. U.K.  Montelukast Sodium Market, By Application, 2024-2035(USD Billion)
  28. Italy Montelukast Sodium Market, By Dosage Form, 2024-2035(USD Billion)
  29. Italy Montelukast Sodium Market, By Application, 2024-2035(USD Billion)
  30. Spain Montelukast Sodium Market, By Dosage Form, 2024-2035(USD Billion)
  31. Spain Montelukast Sodium Market, By Application, 2024-2035(USD Billion)
  32. Asia Pacific Montelukast Sodium Market, By Dosage Form, 2024-2035(USD Billion)
  33. Asia Pacific Montelukast Sodium Market, By Application, 2024-2035(USD Billion)
  34. Japan Montelukast Sodium Market, By Dosage Form, 2024-2035(USD Billion)
  35. Japan Montelukast Sodium Market, By Application, 2024-2035(USD Billion)
  36. China Montelukast Sodium Market, By Dosage Form, 2024-2035(USD Billion)
  37. China Montelukast Sodium Market, By Application, 2024-2035(USD Billion)
  38. India Montelukast Sodium Market, By Dosage Form, 2024-2035(USD Billion)
  39. India Montelukast Sodium Market, By Application, 2024-2035(USD Billion)
  40. South America Montelukast Sodium Market, By Dosage Form, 2024-2035(USD Billion)
  41. South America Montelukast Sodium Market, By Application, 2024-2035(USD Billion)
  42. Brazil Montelukast Sodium Market, By Dosage Form, 2024-2035(USD Billion)
  43. Brazil Montelukast Sodium Market, By Application, 2024-2035(USD Billion)
  44. The Middle East and Africa Montelukast Sodium Market, By Dosage Form, 2024-2035(USD   Billion)
  45. The Middle East and Africa Montelukast Sodium Market, By Application, 2024-2035(USD   Billion)
  46. UAE Montelukast Sodium Market, By Dosage Form, 2024-2035(USD Billion)
  47. UAE Montelukast Sodium Market, By Application, 2024-2035(USD Billion)
  48. South Africa Montelukast Sodium Market, By Dosage Form, 2024-2035(USD Billion)
  49. South Africa Montelukast Sodium Market, By Application, 2024-2035(USD Billion)

List of Figures 

  1. Global Montelukast Sodium Market Segmentation
  2. Montelukast Sodium Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Montelukast Sodium Market
  9. Top Winning Strategies, 2024-2035
  10. Top Winning Strategies, By Development, 2024-2035(%)
  11. Top Winning Strategies, By Company, 2024-2035
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2024
  18. Market Share Analysis, 2024
  19. Restraint and Drivers:  Montelukast Sodium Market
  20. Montelukast Sodium Market Segmentation, By Dosage Form
  21. Montelukast Sodium Market For Tablets, By Region, 2024-2035 ($ Billion)
  22.  Montelukast Sodium Market For Oral Solutions, By Region, 2024-2035 ($ Billion)
  23. Montelukast Sodium Market For Simple Pills, By Region, 2024-2035 ($ Billion)
  24. Montelukast Sodium Market For Chewable Pills, By Region, 2024-2035 ($ Billion)
  25. Montelukast Sodium Market For Others, By Region, 2024-2035 ($ Billion)
  26.  Montelukast Sodium Market Segmentation, By Application
  27.  Montelukast Sodium Market For Asthma, By Region, 2024-2035 ($ Billion)
  28.  Montelukast Sodium Market For Allergic Rhinitis, By Region, 2024-2035 ($ Billion)
  29. Montelukast Sodium Market For Urticaria, By Region, 2024-2035 ($ Billion)
  30. Montelukast Sodium Market For Others , By Region, 2024-2035 ($ Billion)
  31. Cipla: Net Sales, 2024-2035 ($ Billion)
  32. Cipla: Revenue Share, By Segment, 2024 (%)
  33. Cipla: Revenue Share, By Region, 2024 (%)
  34. Merck & Co: Net Sales, 2024-2035 ($ Billion)
  35. Merck & Co: Revenue Share, By Segment, 2024 (%)
  36. Merck & Co: Revenue Share, By Region, 2024 (%)
  37. Hetero Labs: Net Sales, 2024-2035 ($ Billion)
  38. Hetero Labs: Revenue Share, By Segment, 2024 (%)
  39. Hetero Labs: Revenue Share, By Region, 2024 (%)
  40. Ortin laboratories: Net Sales, 2024-2035 ($ Billion)
  41. Ortin laboratories: Revenue Share, By Segment, 2024 (%)
  42. Ortin laboratories: Revenue Share, By Region, 2024 (%)
  43. Mylan N.V: Net Sales, 2024-2035 ($ Billion)
  44. Mylan N.V: Revenue Share, By Segment, 2024 (%)
  45. Mylan N.V: Revenue Share, By Region, 2024 (%)
  46. Morepen laboratories: Net Sales, 2024-2035 ($ Billion)
  47. Morepen laboratories: Revenue Share, By Segment, 2024 (%)
  48. Morepen laboratories: Revenue Share, By Region, 2024 (%)
  49. Teva Pharmaceuticals: Net Sales, 2024-2035 ($ Billion)
  50. Teva Pharmaceuticals: Revenue Share, By Segment, 2024 (%)
  51. Teva Pharmaceuticals: Revenue Share, By Region, 2024 (%)
  52. MSN Laboratories: Net Sales, 2024-2035 ($ Billion)
  53. MSN Laboratories: Revenue Share, By Segment, 2024 (%)
  54. MSN Laboratories: Revenue Share, By Region, 2024 (%)
  55. Vamsi Labs.: Net Sales, 2024-2035 ($ Billion)
  56. Vamsi Labs.: Revenue Share, By Segment, 2024 (%)
  57. Vamsi Labs.: Revenue Share, By Region, 2024 (%)
  58. Medopharm: Net Sales, 2024-2035 ($ Billion)
  59. Medopharm: Revenue Share, By Segment, 2024 (%)
  60. Medopharm: Revenue Share, By Region, 2024 (%)
  61. Others: Net Sales, 2024-2035 ($ Billion)
  62. Others: Revenue Share, By Segment, 2024 (%)
  63. Others: Revenue Share, By Region, 2024 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2023
Tables & Figures:110
Pages:200
Countries covered:17
Companies covered::20
Forecast CAGR:5.64%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies